QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
QuantX Biosciences has raised $85.0M in total funding. The most recent round was Series B. The last funding was announced in February 2026.
QuantX Biosciences's investors include HSG, Lilly Asia Ventures, OrbiMed, Sanofi Ventures, Creacion Ventures.
QuantX Biosciences is headquartered in Princeton, United States.
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
QuantX Biosciences is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"QuantX Biosciences — Funding & Investors." VCBacked, February 9, 2026, https://www.vcbacked.co/company/quantx-biosciences. Accessed September 29, 2026.
VCBacked. (2026). QuantX Biosciences — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/quantx-biosciences
{{cite web |title=QuantX Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/quantx-biosciences |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated